Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > AGM

<< Previous

Bullboard Posts

Next >>

Comment by Jaro1977on Jun 29, 2022 12:24pm

307 Views

Post# 34790775

RE:RE:RE:RE:RE:RE:RE:RE:AGM

They had printed materials for about 50 plus people and in conversation before the AGM they mentioned at past meetings there was standing room only. I think Vaccine is out of there hands and they will not know when the lab updates them. But they are positive

<< Previous

Bullboard Posts

Next >>

BlackRock launches new Bitcoin ETF on Cboe Canada